|
|
Lifeward ltd (NASDAQ: LFWD) |
|
Price: $7.4600
$0.10 
1.290%
|
| Day's High:
| $7.5
| Week Perf:
| 2.33 %
|
| Day's Low: |
$ 7.30 |
30 Day Perf: |
6.57 % |
| Volume (M): |
4,327 |
52 Wk High: |
$ 10.56 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$7.31 |
| Open: |
$7.30 |
52 Wk Low: |
$4.14 |
|
|
| Market Capitalization (Millions $) |
21 |
| Shares
Outstanding (Millions) |
3 |
| Employees |
81 |
| Revenues (TTM) (Millions $) |
22 |
| Net Income (TTM) (Millions $) |
-31 |
| Cash Flow (TTM) (Millions $) |
6 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
The company acquired AlterG, making it an indirect wholly-owned subsidiary, and plans to integrate AlterG's business, operations, and products with its own. It focuses on managing operating expenses and raising capital through equity, debt securities, and other financing methods to develop and commercialize its products. The company faces risks related to economic conditions and integration challenges.
Company Address: 2 Cabot Rd Hudson 1749
Company Phone Number: 251.1154 Stock Exchange / Ticker: NASDAQ LFWD
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Product Service News
Published Tue, Apr 15 2025 12:51 PM UTC
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 Lifeward, a pioneering company at the forefront of medical technology, has announced the launch of the ReWalk 7 personal exoskeleton in the U.S. market. This state-of-the-art seventh-generation device is designed for individuals with spinal cord injuries, enabling greater mobility and independence. The launch re...
|
| Partnership
Published Mon, Mar 10 2025 12:27 PM UTC
Lifeward and MYOLYN have amplified their collaborative efforts to broaden the reach of the MyoCycle Functional Electrical Stimulation (FES) Cycling Therapy System, facilitating greater patient access to this advanced rehabilitation tool for home use. The reinforced partnership, announced recently, grants Lifeward expanded distribution rights to include referral sales for hom...
|
| Shares
Published Wed, Jan 8 2025 9:15 PM UTC
Lifeward Secures $5 Million Through Strategic Direct Offering: A Breakthrough for Rehabilitation SolutionsIn an impressive maneuver signaling its growth momentum, Lifeward Ltd. (Nasdaq: LFWD) announced the successful closing of a $5 million registered direct offering, priced at-the-market under Nasdaq rules, on January 8, 2025. This initiative underscores Lifeward s commitme...
|
| Stock Market Announcement
Published Mon, Jan 13 2025 12:46 PM UTC
On January 13, 2025, Lifeward Ltd. (Nasdaq: LFWD), a leading medical technology company with headquarters in Marlborough, Massachusetts, and Yokneam Ilit, Israel, announced the cancellation of its Extraordinary General Meeting of Shareholders. The meeting, initially scheduled for the same day, was set to discuss key proposals outlined in the company s Definitive Proxy Statem...
|
| Management Announcement
Published Mon, Jan 13 2025 1:30 PM UTC
Lifeward Ltd. (Nasdaq: LFWD), a key player in the healthcare sector focused on rehabilitation and recovery solutions, recently issued a year-end open letter to shareholders detailing its operational and commercial priorities for 2025. The letter provides insights into the company s recent performance, financial health, and strategic direction, signaling a robust outlook for ...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
-11.48 $ |
| Revenues (TTM) |
7.8 $
|
| Cash Flow (TTM) |
2.25 $ |
| Cash |
6.76 $
|
| Book Value |
4.37 $
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
269,407 |
| Net
Income per Employee (TTM) |
-380,617 |
| Receivable Turnover Ratio (TTM) |
3.38 |
| Inventory Turnover Ratio (TTM) |
3.47 |
| Asset Turnover Ratio (TTM) |
0.66 |
|
|
| Per Share |
|
| Earnings (TTM) |
-11.48 $
|
| Revenues (TTM) |
7.8 $ |
| Cash Flow (TTM) |
2.25 $ |
| Cash |
6.76 $
|
| Book Value |
4.37 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Product |
|
 126.89 % |
of total Revenue |
| Europe |
|
20.38 % |
of total Revenue |
| US |
|
97 % |
of total Revenue |
| United States |
|
27.65 % |
of total Revenue |
| Rest Of World |
|
3.73 % |
of total Revenue |
| |
On February 4 2025 the Lifeward Ltd provided following guidance
nnLifeward Ltd. Announces Upcoming Virtual Investor Event to Outline Commercial Strategy and Financial Prospectsnn
nnMarlborough, MA and Yokneam Illit, Israelnn – February 4, 2025 – Lifeward Ltd. (Nasdaq: LFWD), a pioneering force in the realm of advanced medical technology aimed at enhancing the quality of life for individuals facing physical challenges or disabilities, is excited to announce its upcoming virtual Investor Event set to take place on February 20, 2025, starting at 10:00 AM EST.
During this event, the company’s executive leadership team will share insights into Lifeward's commercial strategy, highlight key initiatives, and provide an overview of its financial outlook f...
|
|
|
3.22%